New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

Home health agencies (HHAs) owned by private equity (PE) firms tend to outperform agencies not owned by PE in certain metrics while lagging in others.

Premier has called on CMS to enhance Medicare Advantage and Part D policies for 2026, emphasizing policies to protect access to care, particularly in rural areas.

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

Karoline Leavitt confirmed Tuesday afternoon the downed portals after multiple reports from lawmakers that their states could ...

An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid ...

The National Community Pharmacists Association has told CMS that more than 90% of independent pharmacies may choose to stop stocking drugs included in the Medicare Drug Price Negotiation Program due ...

Fewer than half of Americans in a new poll say they trust President Trump or his health-related nominees to make ...